Business Insider

Bio2 Technologies, Inc. Receives FDA IDE Approval to Begin Clinical Study of Resorbable Cervical Interbody Device for Spinal Fusion

WOBURN, Mass., Nov. 13, 2018 /PRNewswire/ -- Bio2 Technologies, Inc., a privately held orthopedics company, announced today that it received U.S. Food and Drug Administration ("FDA") approval to begin ...
Motorcyclist

Tested: Maxima Bio2 Two-Stroke Oil

Poor fuel economy and far too much unburned gas and oil going out the exhaust caused two-strokes to fall out of favor a long time ago, but some of us still love the simplicity, the sound, and, yes, ...
Medindia

BiO2 Medical Enrolls Subjects in the New U.S. FDA Early Feasibility Pilot Study for the Angel® Catheter

BiO2 Medical, Inc. is proud to announce the Angel® Catheter Early Feasibility Clinical Study has enrolled its first 3 subjects. Research teams led by Dr. John Holcomb at University of Texas, Houston ...
Business Insider

Bio2 Technologies Enrolls First Vitrium Patient in Cervical Spine Fusion Trial

WOBURN, Mass., Aug. 5, 2019 /PRNewswire/ -- Bio2 Technologies, Inc., the developer of Vitrium, a unique proprietary structural and resorbable orthobiomaterial, announced the first implantation of an ...
FierceBiotech

FDA clears catheter to prevent blood clots during hospital stays

The FDA cleared BiO2 Medical’s catheter for the protection of critically ill patients from pulmonary embolism. It is the first venous catheter to be approved for prophylactic use in addition to ...
FierceBiotech

BiO2 Medical pulls in $12M to market catheter

San Antonio-based devicemaker BiO2 Medical snagged $12 million in a Series C round, money the company will use to commercialize its Angel catheter. Remeditex Ventures led the round, joined by BiO2's ...